Zika Pandemic May Push U.S. to Approve Intrexon's (XON) OX513A - Griffin Securities

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Zika Pandemic May Push U.S. to Approve Intrexon's (XON) OX513A - Griffin Securities

Intrexon (XON), Inovio Pharma (INO) Moving Back to Highs on Zika Outbreak

January 28, 2016 11:08 AM EST

After consolidating this morning's move higher, Intrexon (NYSE: XON) and Inovio Pharma (NASDAQ: INO) are moving to the highs following the continued Zika outbreak which the WHO said is "spreading explosively."

... More

Pre-Open Stock Movers 01/28: (NEOS) (UA) (FB) Higher; (NOW) (OSIS) (EBAY) Lower (more...)

January 28, 2016 9:30 AM EST

Neos Therapeutics (NASDAQ: NEOS) 59% HIGHER; the U.S. Food and Drug Administration (FDA) approved Adzenys... More

Intrexon (XON), Inovio Pharma (INO) on Watch as Zika Virus 'Spreading Explosively'

January 28, 2016 8:19 AM EST

Inovio Pharma (NASDAQ: INO) and Intrexon (NYSE: XON) are on watch on reports the Zika virus is "spreading explosively."

The Zika virus is strongly suspected of causing birth defects and may infect 3-4 million people in the Americas, including 1.5 million in Brazil, a World Health Organization expert said on Thursday.

... More